Analysis

The optical networking specialist Lumentum has laid out a bold financial roadmap, aiming to dramatically accelerate its business growth. The...

The biopharmaceutical giant AbbVie finds itself navigating a complex landscape where promising research initiatives are counterbalanced by resurgent legal challenges....

In a decisive move to secure its financial future, New Fortress Energy has announced a sweeping restructuring agreement with its...

The US food distribution giant Sysco finds itself navigating a period of transition within its financial leadership. As Brandon Sewell...

Precision Biosciences is solidifying its clinical development strategy, with a pivotal trial for a Duchenne muscular dystrophy (DMD) treatment taking...

The initial euphoria surrounding artificial intelligence is giving way to a more sober assessment for software providers like Figma. Investors...

Recent clinical trial data from Ocular Therapeutix has generated significant attention within ophthalmology investment circles. The company's key drug candidate,...

The renewable fuels industry is undergoing a significant structural shift. This transformation is creating a new landscape for producers like...

In a volatile market for biotechnology stocks, Corvus Pharmaceuticals has achieved a significant milestone, granting the company a crucial period...

The shares of fintech firm Better Home Finance Holding are currently the focus of significant, yet contrasting, market activity. As...